UNIVERSITY OF VERMONT MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $26.1M
- Transactions
- 4,822
- Companies
- 40
- Average per transaction
- $5,419
Who reported the payments
| Pfizer | $3,118,991 |
| AstraZeneca | $2,658,170 |
| Eli Lilly | $2,601,217 |
| Medtronic | $2,162,882 |
| Roche TCRC, Inc. | $1,585,841 |
| Vertex | $1,443,110 |
| Genentech, Inc. | $1,409,192 |
| Merck | $1,343,648 |
| Boston Scientific | $788,575 |
| F. Hoffmann-la Roche AG | $557,374 |
| EMD Serono, Inc. | $542,165 |
| Janssen Research & Development, LLC | $511,033 |
| Intercept Pharmaceuticals, Inc. | $374,495 |
| AbbVie | $345,928 |
| Abbott | $293,661 |
| Novo Nordisk AS | $292,961 |
| Sanofi | $274,655 |
| Neurocrine Biosciences, Inc. | $263,384 |
| American Regent | $253,168 |
| Astrazeneca UK Limited | $250,849 |
| Amgen | $232,184 |
| Regeneron | $223,959 |
| E.r. Squibb & Sons, L.L.C. | $221,806 |
| Boehringer Ingelheim | $219,779 |
| Akebia Therapeutics Inc | $208,006 |
| Sanofi US Services Inc. | $177,541 |
| Blue Earth Diagnostics | $162,905 |
| Angiodynamics, Inc. | $157,000 |
| Bayer | $154,997 |
| Endotronix, Inc. | $151,713 |
| United Therapeutics Corporation | $145,520 |
| Indivior Inc. | $142,447 |
| Gilead | $141,099 |
| Biogen | $126,032 |
| Sanofi Pasteur Inc. | $123,395 |
| Clovis Oncology, Inc. | $111,594 |
| Roche Products Limited | $106,139 |
| Procept Biorobotics Corporation | $106,099 |
| UCB SA | $101,591 |
| Bausch Health US, LLC | $101,146 |